The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Self-citationHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Self-citationNatural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212203 · Cited by 1,633
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Davis, G. L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S. C., Trepo, C., Shiffman, M. L., Zeuzem, S., Craxi, A., Ling, M.-H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392102 · Cited by 1,282
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
Recombinant Interferon Alfa Therapy for Chronic Hepatitis C
Di Bisceglie, A. M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S. M., & Hoofnagle, J. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212204 · Cited by 1,212
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M., & Albrecht, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33023 · Cited by 1,146
Self-citation[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
A proposed system for the nomenclature of hepatitis C viral genotypes
Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S.-W., Chayama, K., Chen, D.-S., et al. (1994) · Hepatology · doi:10.1002/hep.1840190538 · Cited by 1,023
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Self-citationLong-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G., & Williams, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 969
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 904
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 879
Chung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
RNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes
Bukh, J., Miller, R., & Purcell, R. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007262 · Cited by 833
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 820
Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Self-citationTreatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Self-citationAlter, H. J., & Seeff, L. B. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9505 · Cited by 736
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36810 · Cited by 727
Soto, B., Sánchez-Quijano, A., Rodrigo, L., Olmo, J. A. D., García-Bengoechea, M., Hernández-Quero, J., Rey, C., Abad, M. A., Rodríguez, M., Sales Gilabert, M., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80001-3 · Cited by 701
EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
(1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80154-8 · Cited by 700
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Poynard, T., Leroy, V, Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., & Zarski, J. P. (1996) · Hepatology · doi:10.1002/hep.510240405 · Cited by 671
Lindsay, K. L., Trepo, C., Heintges, T., Shiffman, M. L., Gordon, S. C., Hoefs, J. C., Schiff, E. R., Goodman, Z. D., Laughlin, M., Yao, R., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.26371 · Cited by 668
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Reichard, O., Norkrans, G., Frydén, A., Braconier, J.-H., Sönnerborg, A., & Weiland, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06088-1 · Cited by 629
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Burden of liver disease in the United States: Summary of a workshop
Kim, R. W., Brown, R. S., Terrault, N. A., & El-Serag, H. (2002) · Hepatology · doi:10.1053/jhep.2002.34734 · Cited by 589
Interferon Alfa-2a Therapy in Cryoglobulinemia Associated with Hepatitis C Virus
Misiani, R., Bellavita, P., Fenili, D., Vicari, O., Marchesi, D., Sironi, P. L., Zilio, P., Vernocchi, A., Massazza, M., Vendramin, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301104 · Cited by 583
Projecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 576
Estimating future hepatitis C morbidity, mortality, and costs in the United States
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 567
Variability of hepatitis C virus
Simmonds, P. (1995) · Hepatology · doi:10.1002/hep.1840210243 · Cited by 567
Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00003 · Cited by 559
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Muir, A. J., Bornstein, J. D., & Killenberg, P. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032502 · Cited by 541
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Stramer, S. L., Glynn, S. A., Kleinman, S. H., Strong, D. M., Caglioti, S., Wright, D. J., Dodd, R. Y., & Busch, M. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040085 · Cited by 536
Impact of Hepatitis B and C Virus on Kidney Transplantation Outcome
Mathurin, P., Mouquet, C., Poynard, T., Sylla, C., Benalia, H., Fretz, C., Thibault, V., Cadranel, J.-F., Bernard, B., Opolon, P., et al. (1999) · Hepatology · doi:10.1002/hep.510290123 · Cited by 532
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Aach, R. D., Stevens, C. E., Hollinger, F. B., Mosley, J. W., Peterson, D. A., Taylor, P. E., Johnson, R. G., Barbosa, L. H., & Nemo, G. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251901 · Cited by 523
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G. (1994) · Hepatology · doi:10.1002/hep.1840200611 · Cited by 517
Vogt, M. O., Lang, T., Frösner, G., Klingler, C., Sendl, A., Zeller, A., Wiebecke, B., Langer, B., Meisner, H., & Hess, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411202 · Cited by 502
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
Dienstag, J. L. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90336-0 · Cited by 500
Self-citationIkeda, K., Saitoh, S., Arase, Y., Chayama, K., Suzuki, Y., Kobayashi, M., Tsubota, A., Kobayashi, M., Nakamura, I., Murashima, N., et al. (1999) · Hepatology · doi:10.1002/hep.510290439 · Cited by 467
Benvegnù, L., Gios, M., Boccato, S., & Alberti, A. (2004) · Gut · doi:10.1136/gut.2003.020263 · Cited by 454
Shiffman, M. L., Di Bisceglie, A. M., Lindsay, K. L., Morishima, C., Wright, E. C., Everson, G. T., Lok, A. S., Morgan, T. R., Bonkovsky, H. L., & Lee, W. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.014 · Cited by 453
ZEUZEM, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.007 · Cited by 448
De Franceschi, L., Fattovich, G., Turrini, F., Ayi, K., Brugnara, C., Manzato, F., Noventa, F., Stanzial, A. M., Solero, P., & Corrocher, R. (2000) · Hepatology · doi:10.1053/he.2000.5789 · Cited by 446
Hepatitis C and Progression of HIV Disease
Sulkowski, M. S. (2002) · JAMA · doi:10.1001/jama.288.2.199 · Cited by 445
Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Thorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
Alberti, A., & Benvegnù, L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00008-4 · Cited by 438
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Ikeda, K., Saitoh, S., Suzuki, Y., Kobayashi, M., Tsubota, A., Koida, I., Arase, Y., Fukuda, M., Chayama, K., Murashima, N., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80339-5 · Cited by 428
Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
Hoofnagle, J. H., Peters, M., Mullen, K. D., Jones, D. B., Rustgi, V., Di Bisceglie, A., Hallahan, C., Park, Y., Meschievitz, C., & Jones, E. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90367-8 · Cited by 420
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
Serfaty, L., Aumaître, H., Chazouillères, O., Bonnand, A.-M., Rosmorduc, O., Poupon, R. E., & Poupon, R. Y. (1998) · Hepatology · doi:10.1002/hep.510270535 · Cited by 403
Progression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
Bonkovsky, H. L., & Woolley, M. J. (1999) · Hepatology · doi:10.1002/hep.510290124 · Cited by 398
Laguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., Bargallo, X., García-Criado, A., Lazzari, E. D., Larrousse, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00003 · Cited by 387
Alberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
Bodenheimer, H. C., Lindsay, K. L., Davis, G. L., Lewis, J. H., Thung, S. N., & Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260231 · Cited by 380
Lavanchy, D. (1999) · PubMed · Cited by 374
The role of liver biopsy in chronic hepatitis C
Dienstag, J. L. (2002) · Hepatology · doi:10.1002/hep.1840360720 · Cited by 373
Self-citationBjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., & Haaland, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312402 · Cited by 370
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
Dixit, N. M., Layden-Almer, J. E., Layden, T. J., & Perelson, A. S. (2004) · Nature · doi:10.1038/nature03153 · Cited by 369
Reddy, R. K., Wright, T. L., Pockros, P. J., Shiffman, M., Everson, G., Reindollar, R., Fried, M. W., Purdum, P. P., Jensen, D., Smith, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21747 · Cited by 359
Bressler, B. L., Guindi, M., Tomlinson, G., & Heathcote, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50350 · Cited by 358
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
Dusheiko, G. M., Main, J., Thomas, H. C., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80225-x · Cited by 355
Féray, C., Caccamo, L., Alexander, G. J. M., Ducot, B., Gugenheim, J., Casanovas, T., Loinaz, C., Gigou, M., Burra, P., Barkholt, L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70454-3 · Cited by 354
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Nelson, D. R., Lauwers, G. Y., Lau, J. Y. N., & Davis, G. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70134-x · Cited by 349
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Ribavirin as Therapy for Chronic Hepatitis C: A Randomized, Double-Blind, Placebo-Controlled Trial
Di Bisceglie, A. M., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D. E., Mahaney, K., & Hoofnagle, J. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00001 · Cited by 328
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
Alter, M. J., & Mast, E. E. (1994) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00146-1 · Cited by 324
Monga, H. K., Rodriguez‐Barradas, M. C., Breaux, K., Khattak, K., Troisi, C. L., Velez, M., & Yoffe, B. (2001) · Clinical Infectious Diseases · doi:10.1086/321819 · Cited by 321
Use and interpretation of virological tests for hepatitis C
Pawlotsky, J.-M. (2002) · Hepatology · doi:10.1053/jhep.2002.36815 · Cited by 320
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
Lafeuillade, A., Hittinger, G., & Chadapaud, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03618-7 · Cited by 319
Bennett, W. G., Inoue, Y., Beck, J. R., Wong, J. B., Pauker, S. G., & Davis, G. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00001 · Cited by 315
Cramp, M. E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., & Naoumov, N. V. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70217-4 · Cited by 313
Ning, Q., Brown, D., Parodo, J., Cattral, M., Gorczynski, R., Cole, E., Fung, L., Ding, J. W., Liu, M. F., Rotstein, O., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3487 · Cited by 303
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
Falck-Ytter, Y., Kale, H., Mullen, K. D., Sarbah, S. A., Sorescu, L., & McCullough, A. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00008 · Cited by 301
Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)
Eyster, M. E., Alter, H. J., Aledort, L. M., Quan, S., Hatzakis, A., & Goedert, J. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-764 · Cited by 301
The burden of hepatitis C in the United States
Kim, R. W. (2002) · Hepatology · doi:10.1002/hep.1840360705 · Cited by 299
Optimal therapy of hepatitis C
Di Bisceglie, A. M., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360716 · Cited by 297
Féray, C., Gigou, M., Samuel, D., Paradis, V., Mishiro, S., Maertens, G., Reynés, M., Okamoto, H., Bismuth, H., & Bréchot, C. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90207-4 · Cited by 294
Racial differences in responses to therapy with interferon in chronic hepatitis C
Reddy, R. K., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P., Heathcote, J. E., Albert, D., & Joh, T. (1999) · Hepatology · doi:10.1002/hep.510300319 · Cited by 291
Hepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
The Course of Hepatitis C Virus Infection After Liver Transplantation
Féray, C., Gigou, M., Samuel, D., Paradis, V., Wilber, J., David, M. F., Urdea, M., Reynes, M., Bréchot, C., & Bismuth, H. (1994) · Hepatology · doi:10.1002/hep.1840200506 · Cited by 289
Poynard, T., McHutchison, J., Davis, G. L., Esteban-Mur, R., Goodman, Z., Bedossa, P., & Albrecht, J. (2000) · Hepatology · doi:10.1053/jhep.2000.19347 · Cited by 280
Self-citationWestin, J., Nordlinder, H., Lagging, M., Norkrans, G., & Wejstål, R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00299-4 · Cited by 280
Complementary and alternative medicine in chronic liver disease
Seeff, L. B., Lindsay, K. L., Bacon, B. R., Kresina, T. F., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.27445 · Cited by 271
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
Zeuzem, S., Lee, J., Herrmann, E., Fricke, J., Neumann, A. U., Modi, M., Colucci, G., & Roth, W. K. (2001) · Gastroenterology · doi:10.1053/gast.2001.24006 · Cited by 270
Fibrosis and disease progression in hepatitis C
Marcellin, P., Asselah, T., & Boyer, N. (2002) · Hepatology · doi:10.1002/hep.1840360707 · Cited by 267
10-year follow-up after interferon-α therapy for chronic hepatitis C
Lau, D. T., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H. (1998) · Hepatology · doi:10.1002/hep.510280430 · Cited by 266
Rosenthal, E., Poirée, M., Pradier, C., Perronne, C., Salmon-Ceron, D., Geffray, L., Myers, R. P., Morlat, P., Pialoux, G., Pol, S., et al. (2003) · AIDS · doi:10.1097/00002030-200308150-00009 · Cited by 262
Antiviral action of ribavirin in chronic hepatitis C
Pawlotsky, J., Dahari, H., Neumann, A. U., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.002 · Cited by 262
Side effects of therapy for chronic hepatitis C
Russo, M. W., & Fried, M. W. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00394-9 · Cited by 261
Zeuzem, S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00033 · Cited by 261
Treatment of Hepatitis C Infection in Injection Drug Users
Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25882 · Cited by 256
Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Shiffman, M. L., Hofmann, C. M., Contos, M. J., Luketic, V. A., Sanyal, A. J., Sterling, R. K., Ferreira-Gonzalez, A., Mills, A. S., & Garret, C. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70402-6 · Cited by 254
Sobesky, R., Mathurin, P., Charlotte, F., Moussalli, J., Olivi, M., Vidaud, M., Ratziu, V., Opolon, P., & Poynard, T. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70135-6 · Cited by 252
Bellentani, S., Pozzato, G., Saccoccio, G., Crovatto, M., Crocè, L. S., Mazzoran, L., Masutti, F., Cristianini, G., & Tiribelli, C. (1999) · Gut · doi:10.1136/gut.44.6.874 · Cited by 246
Zeuzem, S., Diago, M., Gane, E., Reddy, K. R., Pockros, P., Prati, D., Shiffman, M., Farci, P., Gitlin, N., O’Brien, C. B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.050 · Cited by 246
Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population
Salomon, J. A. (2003) · JAMA · doi:10.1001/jama.290.2.228 · Cited by 244
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
Lai, M., Kao, J., Yang, P., Wang, J., Chen, P., Chan, K., Chu, J., & Chen, D. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898645 · Cited by 243
Mohsen, A. H., Easterbrook, P. J., Taylor, C., Portmann, B., Kulasegaram, R., Murad, S., Wiselka, M., & Norris, S. (2003) · Gut · doi:10.1136/gut.52.7.1035 · Cited by 241
Molecular diagnosis of viral hepatitis
Pawlotsky, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33428 · Cited by 240
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Interferon therapy prolonged life expectancy among chronic hepatitis C patients
Yoshida, H., Arakawa, Y., Sata, M., Nishiguchi, S., Yano, M., Fujiyama, S., Yamada, G., Yokosuka, O., Shiratori, Y., & Omata, M. (2002) · Gastroenterology · doi:10.1053/gast.2002.34785 · Cited by 235
Epidemiology of hepatitis C in the United States
Williams, I. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00373-3 · Cited by 230
Cammà, C., Di Bona, D., Schepis, F., Heathcote, J. E., Zeuzem, S., Pockros, P. J., Marcellin, P., Balart, L., Alberti, A., & Craxì, A. (2004) · Hepatology · doi:10.1002/hep.20073 · Cited by 227
Alric, L., Fort, M., Izopet, J., Vinel, J., Charlet, J., Selves, J., Puel, J., Pascal, J., Duffaut, M., & Abbal, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352872 · Cited by 220
Lesens, O., Deschênes, M., Steben, M., Bélanger, G., & Tsoukas, C. M. (1999) · The Journal of Infectious Diseases · doi:10.1086/314720 · Cited by 218
McHutchison, J. G., Ware, J. E., Bayliss, M. S., Pianko, S., Albrecht, J. K., Cort, S., Yang, I., & Neary, M. P. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00026-x · Cited by 210
Self-citationZignego, A. L., Ferri, C., Giannelli, F., Giannini, C., Caini, P., Monti, M., Marrocchi, M. E., Di Pietro, E., La Villa, G., Laffi, G., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00008 · Cited by 204
Nelson, D. R., Tu, Z., Soldevila-Pico, C., Abdelmalek, M., Zhu, H., Xu, Y. L., Cabrera, R., Liu, C., & Davis, G. L. (2003) · Hepatology · doi:10.1002/hep.1840380412 · Cited by 202
Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
Edlin, B. R., Seal, K. H., Lorvick, J., Kral, A. H., Ciccarone, D. H., Moore, L. D., & Lo, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450311 · Cited by 202
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
Pérez-Olmeda, M., Núñez, M., Romero, M., González, J., Castro, A., Arribas, J. R., Pedreira, J., Barreiro, P., García-Samaniego, J., Martín-Carbonero, L., et al. (2003) · AIDS · doi:10.1097/00002030-200305020-00011 · Cited by 200
Use and interpretation of virological tests for hepatitis C
Pawlotsky, J.-M. (2002) · Hepatology · doi:10.1002/hep.1840360709 · Cited by 198
Orland, J. R., Wright, T. L., & Cooper, S. (2001) · Hepatology · doi:10.1053/jhep.2001.22112 · Cited by 196
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients [see comments]
Brettler, D., Alter, H., Dienstag, J., Forsberg, A., & Levine, P. (1990) · Blood · doi:10.1182/blood.v76.1.254.254 · Cited by 190
Self-citationTreating hepatitis C in methadone maintenance patients: an interim analysis
Sylvestre, D. L. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00010-8 · Cited by 189
Contreras, A. M., Hiasa, Y., He, W., Terella, A., Schmidt, E. V., & Chung, R. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8505-8517.2002 · Cited by 188
Layden-Almer, J. E., Ribeiro, R. M., Wiley, T., Perelson, A. S., & Layden, T. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50217 · Cited by 184
Long–Term Follow–Up of Patients With Chronic Hepatitis C Treated With α–Interferon
Shindo, M., di Bisceglie, A. M., & Hoofnagle, J. H. (1992) · Hepatology · doi:10.1002/hep.1840150607 · Cited by 180
Fried, M., & Hoofnagle, J. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007265 · Cited by 180
Prevention and treatment of hepatitis C in injection drug users
Edlin, B. R. (2002) · Hepatology · doi:10.1053/jhep.2002.36809 · Cited by 179
Tedaldi, E. M., Baker, R. K., Moorman, A. C., Alzola, C. F., Furhrer, J., McCabe, R. E., Wood, K. C., Holmberg, S. D., & the HIV Outpatient Study (HOPS) Investigators (2003) · Clinical Infectious Diseases · doi:10.1086/345953 · Cited by 177
Berenguer, M., Prieto, M., Córdoba, J., Rayón, J. M., Carrasco, D., Olaso, V., San-Juan, F., Gobernado, M., Mir, J., & Berenguer, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80224-9 · Cited by 173
Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance
Poynard, T., Ratziu, V., Benmanov, Y., Di Martino, V., Bedossa, P., & Opolon, P. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9258 · Cited by 172
Fong, T.-L., Valinluck, B., Govindarajan, S., Charboneau, F., Adkins, R. H., & Redeker, A. G. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90077-9 · Cited by 170
Monitoring of viral levels during therapy of hepatitis C
Davis, G. L. (2002) · Hepatology · doi:10.1053/jhep.2002.36798 · Cited by 168
Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial
Nomura, H., Sou, S., Tanimoto, H., Nagahama, T., Kimura, Y., Hayashi, J., Ishibashi, H., & Kashiwagi, S. (2004) · Hepatology · doi:10.1002/hep.20196 · Cited by 168
Lee, W. M., Dienstag, J. L., Lindsay, K. L., Lok, A. S., Bonkovsky, H. L., Shiffman, M. L., Everson, G. T., Di Bisceglie, A. M., Morgan, T. R., Ghany, M. G., et al. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.003 · Cited by 167
Self-citationPeters, M. G., & Terrault, N. A. (2002) · Hepatology · doi:10.1053/jhep.2002.36811 · Cited by 166
Di Bisceglie, A. M., Bonkovsky, H. L., Chopra, S., Flamm, S., Reddy, R. K., Grace, N., Killenberg, P., Hunt, C., Tamburro, C., Tavill, A. S., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8700 · Cited by 163
Kamal, S. M., Ismail, A., Graham, C. S., He, Q., Rasenack, J. W., Peters, T., Tawil, A. A., Fehr, J. J., Khalifa, K. E. S., Madwar, M. M., et al. (2004) · Hepatology · doi:10.1002/hep.20266 · Cited by 163
Cummings, K. J., Lee, S. M., West, E. S., Cid-Ruzafa, J., Fein, S. G., Aoki, Y., Sulkowski, M. S., & Goodman, S. N. (2001) · JAMA · doi:10.1001/jama.285.2.193 · Cited by 161
Younossi, Z. M., Singer, M. E., McHutchison, J. G., & Shermock, K. M. (1999) · Hepatology · doi:10.1002/hep.510300518 · Cited by 160
Self-citationChung, R. T., Evans, S. R., Yang, Y., Theodore, D., Valdez, H., Clark, R., Shikuma, C., Nevin, T., & Sherman, K. E. (2002) · AIDS · doi:10.1097/00002030-200209270-00008 · Cited by 160
Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnover
Zeuzem, S., Schmidt, J. M., Lee, J.-H., von Wagner, M., Teuber, G., & Roth, K. W. (1998) · Hepatology · doi:10.1002/hep.510280132 · Cited by 159
Host factors and failure of interferon-α treatment in hepatitis C virus
Gao, B., Hong, F., & Radaeva, S. (2004) · Hepatology · doi:10.1002/hep.20139 · Cited by 159
Wong, J. B., & Koff, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00008 · Cited by 155
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K. L., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., & Dienstag, J. L. (1994) · PubMed · Cited by 151
Self-citationInfluence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus
Kuzushita, N., Hayashi, N., Moribe∥, T., Katayama, K., Kanto, T., Nakatani, S., Kaneshige, T., Tatsumi, T., Ito, A., Mochizuki, K., et al. (1998) · Hepatology · doi:10.1002/hep.510270136 · Cited by 145
Hepatitis C and human immunodeficiency virus infection
Thomas, D. L. (2002) · Hepatology · doi:10.1053/jhep.2002.36380 · Cited by 144
Chou, R., Clark, E. C., & Helfand, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00014 · Cited by 131
Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up
Dalgård, O., Bjøro, K., Hellum, K. B., et al. (2002) · European Addiction Research · doi:10.1159/000049487 · Cited by 129
Hepatitis C in African Americans: Summary of a workshop
Howell, C. D., Jeffers, L. J., & Hoofnagle, J. H. (2000) · Gastroenterology · doi:10.1053/gast.2000.19582 · Cited by 127
Ohnishi, K., Matsuo, S., Matsutani, K., Itahashi, M., Kakihara, K., Suzuki, K., Ito, S., & Fujiwara, K. (1996) · PubMed · Cited by 124
Impact of immunosuppressive therapy on recurrence of hepatitis C
Everson, G. T. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35852 · Cited by 121
Clemente, M. G., Congia, M., Lai, M. E., Lilliu, F., Lampis, R., Frau, F., Frau, M. R., Faa, G., Diana, G., Dessì, C., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70138-5 · Cited by 115
Cited by
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
McHutchison, J. G., Everson, G. T., Gordon, S. C., Jacobson, I. M., Sulkowski, M., Kauffman, R., McNair, L., Alam, J., & Muir, A. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806104 · Cited by 1,089
Self-citationMagnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 659
Thrombocytopenia associated with chronic liver disease
Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B., & Esteban, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.009 · Cited by 583
Self-citationDrug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Metadata
- Authors
- Dienstag, J. L., & McHutchison, J. G.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 130
- Issue
- 1
- Pages
- 231-264
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2058720438
- Cited by
- 384
- References
- 265
- FWCI
- 38.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.